Improved glucose homeostasis in obese mice treated with resveratrol is associated with alterations in the gut microbiome

Diabetes

Volumn 66, Issue 2, 2017, Pages 418-425

  Sung, Miranda M ^a   Kim, Ty T ^a   Denou, Emmanuel ^b   Soltys, Carrie Lynn M ^a   Hamza, Shereen M ^a   Byrne, Nikole J ^a   Masson, Grant ^a   Park, Heekuk ^c   Wishart, David S ^c   Madsen, Karen L ^c   Schertzer, Jonathan D ^b   Dyck, Jason R B ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; RESVERATROL; GLUCOSE BLOOD LEVEL; STILBENE DERIVATIVE;

AKKERMANSIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEROIDES; CONTROLLED STUDY; DIET INDUCED OBESITY; DRUG MECHANISM; FECAL MICROBIOTA TRANSPLANTATION; GLUCOSE HOMEOSTASIS; INTESTINE FLORA; LACHNOSPIRACEAE; MALE; MORYELLA; MOUSE; MOUSE MODEL; NONHUMAN; PARABACTEROIDES; PRIORITY JOURNAL; TURICIBACTERACEAE; ANIMAL; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; LIQUID CHROMATOGRAPHY; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; OBESITY; TANDEM MASS SPECTROMETRY;

ANIMALS; BACTEROIDES; BLOOD GLUCOSE; CHROMATOGRAPHY, LIQUID; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; MALE; MICE; MICE, OBESE; OBESITY; STILBENES; TANDEM MASS SPECTROMETRY;

EID: 85011700296     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-0680     Document Type: Article

References (39)

1. Hausenblas HA, Schoulda JA, Smoliga JM. Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus-systematic review and meta-Analysis. Mol Nutr Food Res 2015;59:147-159
2. Liu K, Zhou R, Wang B, Mi MT. Effect of resveratrol on glucose control and insulin sensitivity: a meta-Analysis of 11 randomized controlled trials. Am J Clin Nutr 2014;99:1510-1519
3. Dao TM, Waget A, Klopp P, et al. Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control. PLoS One 2011;6:e20700
4. Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 2016;8:42
5. Baur JA. Biochemical effects of SIRT1 activators. Biochim Biophys Acta 2010;1804:1626-1634
6. Cǒté CD, Rasmussen BA, Duca FA, et al. Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network. Nat Med 2015;21:498-505
7. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727-747
8. Qiao Y, Sun J, Xia S, Tang X, Shi Y, Le G. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Funct 2014;5:1241-1249
9. Etxeberria U, Arias N, Boqué N, et al. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. J Nutr Biochem 2015;26:651-660
10. de Ligt M, Timmers S, Schrauwen P. Resveratrol and obesity: can resveratrol relieve metabolic disturbances? Biochim Biophys Acta 2015;1852:1137-1144
11. Koonen DP, Sung MM, Kao CK, et al. Alterations in skeletal muscle fatty acid handling predisposes middle-Aged mice to diet-induced insulin resistance. Diabetes 2010;59:1366-1375
12. Perry T, Jovel J, Patterson J, et al. Fecal Microbial Transplant After Ileocolic Resection Reduces Ileitis but Restores Colitis in IL-10-/-Mice. Inflamm Bowel Dis 2015;21:1479-1490
13. Denou E, Lolméde K, Garidou L, et al. Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance. EMBO Mol Med 2015;7:259-274
14. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 2011;17:10-12
15. Masella AP, Bartram AK, Truszkowski JM, Brown DG, Neufeld JD. PANDAseq: paired-end assembler for illumina sequences. BMC Bioinformatics 2012;13:31
16. Ye Y. Identification and quantification of abundant species from pyrosequences of 16S rRNA by consensus alignment. In Proceedings of the 2011 IEEE International Conference on Bioinformatics and Biomedicine, Atlanta, GA, 2011. New York, IEEE, p. 153-157
17. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-336
18. DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006;72:5069-5072
19. Langille MG, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013;31:814-821
20. Zordoky BN, Sung MM, Ezekowitz J, et al.; Alberta HEART. Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One 2015;10: e0124844
21. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60
22. Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008;8:157-168
23. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006;127:1109-1122
24. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337-342
25. Barlow GM, Yu A, Mathur R. Role of the Gut Microbiome in Obesity and Diabetes Mellitus. Nutr Clin Pract 2015;30:787-797
26. Chen ML, Yi L, Zhang Y, et al. Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. MBio 2016;7:e02210-e02215
27. Denou E, Marcinko K, Surette MG, Steinberg GR, Schertzer JD. Highintensity exercise training increases the diversity and metabolic capacity of the mouse distal gut microbiota during diet-induced obesity. Am J Physiol Endocrinol Metab 2016;310:E982-E993
28. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-1031
29. Hartstra AV, Bouter KE, Bäckhed F, Nieuwdorp M. Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 2015;38:159-165
30. Mavilio M, Marchetti V, Fabrizi M, et al. A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction. Cell Rep 2016; 16:731-743
31. Pomié C, Blasco-Baque V, Klopp P, et al. Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia. Mol Metab 2016;5:392-403
32. Nøhr MK, Dudele A, Poulsen MM, et al. LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol. PLoS One 2016;11:e0146840
33. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-1772
34. Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol 2015;33:496-503
35. Carvalho FA, Koren O, Goodrich JK, et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 2012;12:139-152
36. Treede I, Braun A, Sparla R, et al. Anti-inflammatory effects of phosphatidylcholine. J Biol Chem 2007;282:27155-27164
37. Villarreal-Pérez JZ, Villarreal-Martínez JZ, Lavalle-González FJ, et al. Plasma and urine metabolic profiles are reflective of altered beta-oxidation in nondiabetic obese subjects and patients with type 2 diabetes mellitus. Diabetol Metab Syndr 2014;6:129
38. Dao MC, Everard A, Aron-Wisnewsky J, et al.; MICRO-Obes Consortium. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 2016;65:426-436
39. Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 2013;110:9066-9071